Literature DB >> 17921454

Spatiotemporal expression of ameloblastin isoforms during murine tooth development.

Rajeswari M H Ravindranath1, Asokan Devarajan, Takashi Uchida.   

Abstract

Ameloblasts synthesize and secrete the enamel matrix proteins (amelogenin, ameloblastin, and enamelin). This investigation examined the profiles of ameloblastin in the ameloblasts and in the enamel matrix during different postnatal (PN) days (days 0-9) of development of mouse molar, using an antibody specific for C-terminal sequence of ameloblastin (Ct; GNKVHQPQVHNAWRF). Ameloblastin is found in three different molecular sizes (37, 55, and 66 kDa) in both ameloblasts and enamel matrix during PN development. In the ameloblasts, the sequence of expression of these fractions varied. The 37-kDa fraction was observed (even before the appearances of mRNA of the proteases, enamelysin and kallikrein-4) on days 0 and 1, persisted until day 3, and was not found thereafter. Other isoforms (55 and 66 kDa) distinctly appeared in ameloblasts after day 1, reached a peak on day 5, and remained thereafter. The Ct-positive granules appeared beaded in the ameloblasts on day 3. In the extracellular matrix, a 37-kDa (but not 66- or 55-kDa) fraction was detected on days 0 and 1 and remained in the matrix throughout the PN days. The larger isoforms (55 and 66 kDa) appeared in the enamel matrix from day 3 onward. On days 0-3, but not later, the 37-kDa isoform co-localizes with amelogenin in Tomes' process and formative enamel, as revealed by laser scan confocal microscopy. Autoradiography confirmed accumulation of 3H-labeled amelogenin trityrosyl motif peptide in the region of Tomes' process and formative enamel from day 0 to 3. These observations suggest that the 37-kDa isoform interacts with amelogenin during early tooth development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17921454     DOI: 10.1074/jbc.M704731200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Ameloblastin regulates osteogenic differentiation by inhibiting Src kinase via cross talk between integrin beta1 and CD63.

Authors:  Shinji Iizuka; Yasusei Kudo; Maki Yoshida; Takaaki Tsunematsu; Yuji Yoshiko; Takashi Uchida; Ikuko Ogawa; Mutsumi Miyauchi; Takashi Takata
Journal:  Mol Cell Biol       Date:  2010-12-13       Impact factor: 4.272

2.  Dental cell sheet biomimetic tooth bud model.

Authors:  Nelson Monteiro; Elizabeth E Smith; Shantel Angstadt; Weibo Zhang; Ali Khademhosseini; Pamela C Yelick
Journal:  Biomaterials       Date:  2016-08-17       Impact factor: 12.479

3.  Expression of odontogenic ameloblast-associated protein (ODAM) in dental and other epithelial neoplasms.

Authors:  Daniel P Kestler; James S Foster; Sallie D Macy; Charles L Murphy; Deborah T Weiss; Alan Solomon
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

4.  Critical role of heparin binding domains of ameloblastin for dental epithelium cell adhesion and ameloblastoma proliferation.

Authors:  Akira Sonoda; Tsutomu Iwamoto; Takashi Nakamura; Emiko Fukumoto; Keigo Yoshizaki; Aya Yamada; Makiko Arakaki; Hidemitsu Harada; Kazuaki Nonaka; Seiji Nakamura; Yoshihiko Yamada; Satoshi Fukumoto
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

5.  Analysis of co-assembly and co-localization of ameloblastin and amelogenin.

Authors:  Parichita Mazumder; Saumya Prajapati; Sowmya Bekshe Lokappa; Victoria Gallon; Janet Moradian-Oldak
Journal:  Front Physiol       Date:  2014-07-25       Impact factor: 4.566

6.  Ameloblastin peptide encoded by exon 5 interacts with amelogenin N-terminus.

Authors:  Jingtan Su; Karthik Balakrishna Chandrababu; Janet Moradian-Oldak
Journal:  Biochem Biophys Rep       Date:  2016-05-10

7.  Ameloblastin Peptides Modulates the Osteogenic Capacity of Human Mesenchymal Stem Cells.

Authors:  Øystein Stakkestad; Ståle P Lyngstadaas; Jiri Vondrasek; Jan O Gordeladze; Janne Elin Reseland
Journal:  Front Physiol       Date:  2017-02-07       Impact factor: 4.566

8.  Characterization of AMBN I and II Isoforms and Study of Their Ca2+-Binding Properties.

Authors:  Veronika Vetyskova; Monika Zouharova; Lucie Bednarova; Ondřej Vaněk; Petra Sázelová; Václav Kašička; Jiri Vymetal; Jaroslav Srp; Michaela Rumlová; Tatsiana Charnavets; Klara Postulkova; Janne E Reseland; Kristyna Bousova; Jiri Vondrasek
Journal:  Int J Mol Sci       Date:  2020-12-05       Impact factor: 5.923

9.  An ameloblastin C-terminus variant is present in human adipose tissue.

Authors:  Øystein Stakkestad; Catherine Heyward; Ståle Petter Lyngstadaas; Tirill Medin; Jiri Vondrasek; Aina-Mari Lian; Gita Pezeshki; Janne Elin Reseland
Journal:  Heliyon       Date:  2018-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.